Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Erasure of methylation imprint at the promoter and CTCF-binding site upstream of H19 in human testicular germ cell tumors of adolescents indicate their fetal germ cell origin

Oncogene volume 25, pages 3225–3236 (2006)Cite this article

Abstract

Genome-wide epigenetic modification plays a crucial role in regulating genome functions at critical stages of development. In particular, DNA methylation is known to be reprogrammed on a genome-wide level in germ cells and in preimplantation embryos, although it is relatively stable in somatic cells. In this reprogramming process, the genome becomes demethylated, and methylated de novo during later stages of development. Reprogramming of DNA methylation in male germ cells has not been fully investigated. Testicular germ cell tumors (TGCTs) possess a pluripotential nature and display protean histology from germ cells to embryonal and somatic cell differentiation. These properties make TGCT a unique model for studying germ cell development and gametogenesis in respect of DNA reprogramming. In order to obtain an insight into the epigenetic dynamics of TGCTs, we conducted a comprehensive analysis of differential methylated regions (DMRs) on H19 and IGF2 in TGCTs compared with testicular malignant lymphomas. In the present study, we show that methylation imprint at the promoter and CTCF-binding site upstream of H19 was completely erased in both seiminomatous and non-seminomatous TGCTs, whereas differential methylation was observed in testicular lymphomas. The erasure of methylation imprint was also observed in TGCTs with malignant transformation. We found biallelic unmethylation at the promoter and the CTCF-binding site upstream of H19 is required, but not sufficient for the biallelic expression of H19 in TGCTs. These data suggest that factors other than methylation contribute to transcriptional regulation of imprinted genes in TGCTs. The present data have shown that TGCTs carry distinctive epigenetic profiles at the core-imprinting domain of H19/IGF2 from other neoplasms of somatic cell origin. The data also suggest that both seminomatous and non-seminomatous TGCTs carry methylation profiles similar to fetal germ cells, but not adult germ cells, indicating the origin of TGCTs as fetal germ cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

Accession codes

Accessions

GenBank/EMBL/DDBJ

References

  • Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JW . (1992). Am J Hum Genet 51: 1229–1239.

  • Barlow DP . (1993). Science 260: 309–310.

  • Bartolomei MS, Webber AL, Brunkow ME, Tilghman SM . (1993). Genes Dev 7: 1663–1673.

  • Bell AC, Felsenfeld G . (2000). Nature 405: 482–485.

  • Brandeis M, Kafri T, Ariel M, Chaillet JR, McCarrey J, Razin A et al. (1993). EMBO J 12: 3669–3677.

  • Clark SJ, Harrison J, Paul CL, Frommer M . (1994). Nucleic Acids Res 22: 2990–2997.

  • Cui H, Niemitz EL, Ravenel JD, Onyango P, Brandenburg SA, Lobanenkov VV et al. (2001). Cancer Res 61: 4947–4950.

  • Davis TL, Yang GJ, McCarrey JR, Bartolomei MS . (2000). Hum Mol Genet 9: 2885–2894.

  • Feinberg AP, Tycko B . (2004). Nat Rev Cancer 4: 143–153.

  • Ferguson-Smith AC, Sasaki H, Cattanach BM, Surani MA . (1993). Nature 362: 751–755.

  • Frevel MA, Sowerby SJ, Petersen GB, Reeve AE . (1999). J Biol Chem 274: 29331–29340.

  • Grant M, Zuccotti M, Monk M . (1992). Nat Genet 2: 161–166.

  • Hajkova P, Erhardt S, Lane N, Haaf T, El-Maarri O, Reik W et al. (2002). Mech Dev 117: 15–23.

  • Hark AT, Schoenherr CJ, Katz DJ, Ingram RS, Levorse JM, Tilghman SM . (2000). Nature 405: 486–489.

  • Holstein AF . (1993). Eur Urol 23 (Suppl 2): 9–18.

  • Huber R, Hansen RS, Strazzullo M, Pengue G, Mazzarella R, D'Urso M et al. (1999). Proc Natl Acad Sci USA 96: 616–621.

  • Jaenisch R . (1997). Trends Genet 13: 323–329.

  • Jinno Y, Sengoku K, Nakao M, Tamate K, Miyamoto T, Matsuzaka T et al. (1996). Hum Mol Genet 5: 1155–1161.

  • Jorgensen N, Rajpert-DeMeyts E, Graem N, Muller J, Giwercman A, Skakkebaek NE . (1995). Lab Invest 72: 223–231.

  • Kafri T, Ariel M, Brandeis M, Shemer R, Urven L, McCarrey J et al. (1992). Genes Dev 6: 705–714.

  • Kato Y, Rideout III WM, Hilton K, Barton SC, Tsunoda Y, Surani MA . (1999). Development 126: 1823–1832.

  • Kawakami T, Okamoto K, Ogawa O, Okada Y . (2004a). Lancet 363: 40–42.

  • Kawakami T, Okamoto K, Sugihara H, Hattori T, Reeve AE, Ogawa O et al. (2003). J Urol 169: 1546–1552.

  • Kawakami T, Zhang C, Taniguchi T, Kim CJ, Okada Y, Sugihara H et al. (2004b). Oncogene 23: 6163–6169.

  • Kerjean A, Dupont JM, Vasseur C, Le Tessier D, Cuisset L, Paldi A et al. (2000). Hum Mol Genet 9: 2183–2187.

  • Kirchgessner CU, Warren ST, Willard HF . (1995). J Med Genet 32: 925–929.

  • Klenova EM, Morse III HC, Ohlsson R, Lobanenkov VV . (2002). Semin Cancer Biol 12: 399–414.

  • Lee J, Inoue K, Ono R, Ogonuki N, Kohda T, Kaneko-Ishino T et al. (2002). Development 129: 1807–1817.

  • Li E . (2002). Nat Rev Genet 3: 662–673.

  • Looijenga LH, Stoop H, de Leeuw HP, de Gouveia Brazao CA, Gillis AJ, van Roozendaal KE et al. (2003). Cancer Res 63: 2244–2250.

  • Loukinov DI, Pugacheva E, Vatolin S, Pack SD, Moon H, Chernukhin I et al. (2002). Proc Natl Acad Sci USA 99: 6806–6811.

  • Moller H . (1989). J Natl Cancer Inst 81: 1668–1669.

  • Moulton T, Crenshaw T, Hao Y, Moosikasuwan J, Lin N, Dembitzer F et al. (1994). Nat Genet 7: 440–447.

  • Nakagawa H, Chadwick RB, Peltomaki P, Plass C, Nakamura Y, de La Chapelle A . (2001). Proc Natl Acad Sci USA 98: 591–596.

  • Nonomura N, Miki T, Nishimura K, Kanno N, Kojima Y, Okuyama A . (1997). J Urol 157: 1977–1979.

  • Ogawa O, Eccles MR, Szeto J, McNoe LA, Yun K, Maw MA et al. (1993). Nature 362: 749–751.

  • Okano M, Bell DW, Haber DA, Li E . (1999). Cell 99: 247–257.

  • Oosterhuis JW, Looijenga LH . (2005). Nat Rev Cancer 5: 210–222.

  • Rainier S, Johnson LA, Dobry CJ, Ping AJ, Grundy PE, Feinberg AP . (1993). Nature 362: 747–749.

  • Rajpert-De Meyts E, Hanstein R, Jorgensen N, Graem N, Vogt PH, Skakkebaek NE . (2004). Hum Reprod 19: 1338–1344.

  • Reik W, Dean W, Walter J . (2001). Science 293: 1089–1093.

  • Ross JA, Schmidt PT, Perentesis JP, Davies SM . (1999). Cancer 85: 1389–1394.

  • Shiota K, Yanagimachi R . (2002). Differentiation 69: 162–166.

  • Skakkebaek NE . (1972). Lancet 2: 516–517.

  • Skakkebaek NE, Berthelsen JG, Giwercman A, Muller J . (1987). Int J Androl 10: 19–28.

  • Smiraglia DJ, Szymanska J, Kraggerud SM, Lothe RA, Peltomaki P, Plass C . (2002). Oncogene 21: 3909–3916.

  • Steenman MJ, Rainier S, Dobry CJ, Grundy P, Horon IL, Feinberg AP . (1994). Nat Genet 7: 433–439.

  • Sullivan MJ, Taniguchi T, Jhee A, Kerr N, Reeve AE . (1999). Oncogene 18: 7527–7534.

  • Szabo PE, Mann JR . (1995a). Genes Dev 9: 3097–3108.

  • Szabo PE, Mann JR . (1995b). Genes Dev 9: 1857–1868.

  • Tada T, Tada M, Hilton K, Barton SC, Sado T, Takagi N et al. (1998). Dev Genes Evol 207: 551–561.

  • Takai D, Gonzales FA, Tsai YC, Thayer MJ, Jones PA . (2001). Hum Mol Genet 10: 2619–2626.

  • Taniguchi T, Sullivan MJ, Ogawa O, Reeve AE . (1995). Proc Natl Acad Sci USA 92: 2159–2163.

  • Thorvaldsen JL, Duran KL, Bartolomei MS . (1998). Genes Dev 12: 3693–3702.

  • Ulaner GA, Yang Y, Hu JF, Li T, Vu TH, Hoffman AR . (2003). Endocrinology 144: 4420–4426.

  • Ulbright TM . (1993). Am J Surg Pathol 17: 1075–1091.

  • van Gurp RJ, Oosterhuis JW, Kalscheuer V, Mariman EC, Looijenga LH . (1994). J Natl Cancer Inst 86: 1070–1075.

  • Verkerk AJ, Ariel I, Dekker MC, Schneider T, van Gurp RJ, de Groot N et al. (1997). Oncogene 14: 95–107.

  • Villar AJ, Eddy EM, Pedersen RA . (1995). Dev Biol 172: 264–271.

  • Vu TH, Li T, Nguyen D, Nguyen BT, Yao XM, Hu JF et al. (2000). Genomics 64: 132–143.

  • Yun K, Soejima H, Merrie AE, McCall JL, Reeve AE . (1999). J Pathol 187: 518–522.

  • Zhang C, Kawakami T, Okada Y, Okamoto K . (2005). Genes Chromosomes Cancer 43: 104–112.

  • Zhang Y, Shields T, Crenshaw T, Hao Y, Moulton T, Tycko B . (1993). Am J Hum Genet 53: 113–124.

Download references

Acknowledgements

This work was supported by Grants-in-aid 16390462 and 17390438 from the Ministry of Education, Culture, Sports, Science and Technology, Japan and Research Grant from Takeda Science Foundation and Research Grant for the Princess Takamatsu Cancer Research Fund (04-23603).

Author information

Author notes

  1. T Kawakami and C Zhang: These authors have equally contributed to this work.

Authors and Affiliations

  1. Department of Urology, Shiga University of Medical Science, Otsu, Shiga, Japan

    T Kawakami, C Zhang, Y Okada & K Okamoto

Authors
  1. T Kawakami
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Y Okada
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K Okamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K Okamoto.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kawakami, T., Zhang, C., Okada, Y. et al. Erasure of methylation imprint at the promoter and CTCF-binding site upstream of H19 in human testicular germ cell tumors of adolescents indicate their fetal germ cell origin. Oncogene 25, 3225–3236 (2006). https://doi.org/10.1038/sj.onc.1209362

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1209362

Keywords

This article is cited by

Search

Advanced search

Quick links